Is Oral Tirzepatide FDA-Approved
no new safety concerns emerged in analyses of safety data from STEPs 1 to 4
Many of these studies are from large databases, which are powerful tools in elucidating patterns on a population level, but can also be misleading due to their immense statistical power
Navigating Retatrutide's Side Effects Retatrutide is associated with side effects common to GLP-1 agonists, such as nausea, diarrhea, vomiting, and constipation
Understanding these risks enables informed decision-making and appropriate monitoring
GLP-1RAs mimic endogenous GLP-1, stimulating insulin release from the pancreas, suppressing glucagon secretion, slowing gastric emptying and increasing satiety